ERBB2 and inflammatory breast carcinoma: Metastatic breast cancer (mBC), particularly HER2-negative subtypes such as triple-negative breast cancer (TNBC), inflammatory breast cancer (IBC), and hormone receptor-positive (HR+) breast cancer, is associated with poor prognoses and limited treatment options.